| View |
|
DRP-4532-01
|
Paracetamol
|
Paraglee Forte
|
600 mg
|
Tablet
|
Analgesic/Antipyretic (Anilide)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
|
21 July 2023
|
23 July 2028
|
| View |
|
DRP-4067-04
|
Cetirizine Hydrochloride
|
Gleezine
|
2.5 mg/mL
|
Syrup (Oral Drops)
|
Antihistamine (Piperazine derivative)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
24 October 2022
|
19 October 2028
|
| View |
|
DRP-3601-05
|
Ceftriaxone Sodium
|
Medtrixon
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
12 February 2024
|
14 February 2029
|
| View |
|
DRP-1324-04
|
Co-Amoxiclav
|
Prevaclav 625
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor Combination)
|
Sun Pharmaceutical Industries Limited
|
India
|
-
|
24 June 2022
|
17 June 2027
|
| View |
|
DRP-1826-01
|
ASCORBIC ACID ( as Sodium Ascorbate)
|
Meed-Cee
|
600 mg (equivalent to 674.91mg Sodium Ascorbate)
|
Capsule
|
Vitamin
|
Eurasia Research Pharma Corporation
|
Philippines
|
Renewal
|
12 June 2024
|
06 May 2029
|
| View |
|
DRP-5754-11
|
CETIRIZINE DIHYDROCHLORIDE
|
F-ZEEN
|
2.5 mg/mL
|
Suspension (Oral Drops) (Lemon Flavor)
|
H1-Receptor Antagonist
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
Renewal
|
03 January 2024
|
12 March 2029
|
| View |
|
DRP-9824-01
|
Ascorbic Acid + Zinc
|
Kalxium+
|
500 mg (equivalent to 605.20 mg Calcium Ascorbate)/20 mg (equivalent to 55 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
24 June 2022
|
15 June 2026
|
| View |
|
DRP-10160-01
|
Ascorbic Acid + Zinc
|
Kalxium+ZG
|
500 mg (equivalent to 605.2 mg Calcium Ascorbate)/4.3 mg (equivalent to 30 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
24 June 2022
|
02 August 2026
|
| View |
|
DRP-10204-01
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
Muravit Cee Plus D
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/ 400 IU/ 20 mg (equivalent to 54.90 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamins/Mineral
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
24 June 2022
|
06 August 2026
|
| View |
|
DRP-10868-03
|
Ascorbic Acid + Zinc
|
Bettercee
|
533.40 mg (equivalent to 600 mg Sodium Ascorbate) + 10mg (equivalent to 27.45 mg Zinc Sulfate)
|
Capsule
|
VITAMIN/MINERAL
|
Eurasia Research Pharma Corporation
|
Philippines
|
-
|
24 June 2022
|
30 October 2025
|
| View |
|
DRP-11080-02
|
Ceftriaxone (as Sodium) + Sulbactam (As Sodium)
|
Trilacgen
|
1g/500mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin/Beta-lactamase Inhibitor)
|
Reyoung Pharmaceutical Co. Ltd.
|
China
|
-
|
24 June 2022
|
26 January 2027
|
| View |
|
DRP-5493-02
|
Etoricoxib
|
Etoxib 120
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 March 2024
|
28 August 2029
|
| View |
|
DRP-5515-03
|
Piperacillin (as sodium) / Tazobactam (as sodium)
|
Pitzomac
|
2 g/ 250 mg
|
Powder for Injection (IV)
|
Antibacterial
|
Zeiss Pharmaceuticals Pvt. Ltd.
|
India
|
Renewal
|
16 April 2024
|
12 November 2029
|
| View |
|
DRP-5683-16
|
CEFIXIME
|
TGXIME
|
20 mg/mL
|
Granules for Suspension (oral drops)
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
Renewal
|
29 February 2024
|
20 February 2029
|
| View |
|
DRP-12145
|
Ceftazidime (as pentahydrate)
|
Auromitaz 1000
|
1 g
|
Powder for Injection (IM/IV)
|
-
|
Aurobindo Pharma Limited
|
India
|
-
|
21 June 2022
|
03 October 2026
|
| View |
|
DRP-12146
|
Alfuzosin hydrochloride
|
Adzosin
|
10 mg
|
Sustained-Release Tablet
|
-
|
Aurobindo Pharma Limited Unit III
|
India
|
-
|
21 June 2022
|
19 January 2027
|
| View |
|
HRP-097-04
|
Ascorbic Acid
|
Ascor-Kid
|
100 mg/5 mL
|
Syrup
|
Vitamins
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
-
|
20 June 2022
|
05 February 2027
|
| View |
|
DRP-2511-07
|
Atorvastatin (as calcium) + Amlodipine (as besilate)
|
Amlitor 5
|
10 mg/5 mg
|
Film-Coated Tablet
|
HMG-CoA reductase inhibitor/ Calcium channel blocker
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
22 March 2023
|
07 October 2028
|
| View |
|
DRP-3294-03
|
Ascorbic Acid + Zinc
|
None
|
100 mg/10 mg per 5 mL
|
Syrup
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
20 June 2022
|
03 October 2026
|
| View |
|
DRP-3330-01
|
Ascorbic Acid + Zinc (as heptahydrate)
|
None
|
100 mg/10 mg per mL
|
Syrup (Oral Drops)
|
Vitamin/Mineral
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
20 June 2022
|
18 October 2026
|